Table 2.
Clinical and Virologic Characteristics of HRV URTI and LRTI Episodes
| Characteristic | URTI (N = 183) |
LRTI (N = 262) |
Total (N = 445) |
|||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| Location of initial care | ||||||
| ED | 158 | 86 | 252 | 96 | 410 | 92 |
| UC | 25 | 14 | 10 | 4 | 35 | 8 |
| Fever (temperature > 38.0°C) | 59 | 32 | 47 | 18 | 106 | 24 |
| Admitted to hospital | 31 | 17 | 200 | 76 | 231 | 52 |
| Hospitalized for ≥3 days | 6 | 3 | 46 | 18 | 52 | 12 |
| Coinfection present | 20 | 11 | 46 | 18 | 66 | 15 |
| Viruses in sample | ||||||
| HRV only | 163 | 89 | 216 | 82 | 379 | 85 |
| HRV and RSV | 9 | 5 | 30 | 12 | 39 | 9 |
| HRV and parainfluenza | 4 | 2 | 2 | 1 | 6 | 1 |
| HRV and hMPV | 6 | 3 | 11 | 4 | 17 | 4 |
| HRV and multiple viruses* | 1 | 1 | 3 | 0 | 4 | 0 |
| Supplemental oxygen administered | 1 | 1 | 49 | 19 | 50 | 11 |
| Antibiotics administered | 13 | 7 | 69 | 26 | 82 | 18 |
| Steroids administered | 2 | 1 | 72 | 28 | 74 | 17 |
| Albuterol during hospitalization | 0 | 0 | 95 | 36 | 95 | 21 |
| Intravenous fluids | 24 | 13 | 115 | 44 | 139 | 31 |
| Admitted to the intensive care unit | 2 | 1 | 12 | 5 | 14 | 3 |
| Intensive care unit stay for ≥3 days | 0 | 0 | 8 | 3 | 8 | 2 |
| Patient died | 2 | 1 | 2 | 1 | 4 | 1 |
*Includes HRV, RSV, and hMPV (n = 1 [0%]), HRV, RSV, and CoV (n = 2 [0%]), and HRV, hMPV, and CoV (n = 1 [0%]).